Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Feb 5, 2026
- Accession no.
- 0001231589-26-000003
- Filed
- Feb 5, 2026
- Trade date
- Feb 5, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.01M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | MOption exerciseAcquired | +8,300 | $146.03 | +$1,212,049 | 45,081 | Direct | |
| Feb 5, 2026 | Common Stock | SSaleDisposed | −477 | $480.92F2 | −$229,398.84 | 44,604 | Direct | |
| Feb 5, 2026 | Common Stock | SSaleDisposed | −2,363 | $481.93F3 | −$1,138,800.59 | 42,241 | Direct | |
| Feb 5, 2026 | Common Stock | SSaleDisposed | −1,103 | $482.57F4 | −$532,274.71 | 41,138 | Direct | |
| Feb 5, 2026 | Common Stock | SSaleDisposed | −2,748 | $483.92F5 | −$1,329,812.16 | 38,390 | Direct | |
| Feb 5, 2026 | Common Stock | SSaleDisposed | −934 | $484.92F6 | −$452,915.28 | 37,456 | Direct | |
| Feb 5, 2026 | Common Stock | SSaleDisposed | −675 | $485.52F7 | −$327,726 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Common Stock | MOption exerciseDisposed | −8,300 | $0.00 | $0 | 50,100 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $480.21 to $481.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $481.29 to $482.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $482.29 to $483.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $483.32 to $484.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $484.32 to $485.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $485.34 to $485.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.